Coccidioidomycosis in Patients Treated with Ruxolitinib

Yael Kusne, Kathryn E. Kimes, Fionna F. Feller, Roberto Patron, Juan Gea Banacloche, Janis E. Blair, Holenarasipur R. Vikram, Neil M. Ampel

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.

Original languageEnglish (US)
Article numberofaa167
JournalOpen Forum Infectious Diseases
Issue number6
StatePublished - May 19 2020


  • coccidioidomycosis
  • fungal infections
  • immunocompromised host
  • ruxolitinib

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology


Dive into the research topics of 'Coccidioidomycosis in Patients Treated with Ruxolitinib'. Together they form a unique fingerprint.

Cite this